NCT05241886|Completed
Evaluation of Sarcopenia With SARC-F and Anthropometric Measurement
Evaluation Of Sarcopenia By Adding Anthropometric Measurements To The SARC-F Questionnaire
Loading search results
Evaluation Of Sarcopenia By Adding Anthropometric Measurements To The SARC-F Questionnaire
Sponsor study identifier
observational
190
1 country
1
Study Start
July 1, 2018
Actual (reported)Primary Completion
March 2, 2019
Actual (reported)Study Completion
May 30, 2019
Actual (reported)The aim of this study is to examine the performance of determining the sarcopenia by anthropometric measurements (mid-upper arm circumference and calf circumference) added to the SARC-F questionnaire developed as a screening tool for the risk of sarcopenia in the community-dwelling older adults. The risk of sarcopenia of the individuals over 65 years of age who applied to the Geriatrics Department of Ege University Medical Faculty Hospital Internal Diseases Department. was determined by the SARC-F questionnaire, muscle mass was established by bioelectrical impedance analysis, muscle strength was assessed by handgrip strength, physical performance was assessed by a 4-meter walking test and presence of malnutrition was assessed with an MNA-long form. For the diagnosis of sarcopenia; old (EWGSOP 1) and revised (EWGSOP 2) diagnostic criteria of Sarcopenia Study Group in Elderly Individuals of the European Union Geriatric Medicine Association were used. New parameters were obtained by adding calf circumference (SARC-CC) and mid-upper arm circumference (SARC-MUAC) measurements were added separately and together (SARC-CC-MUAC) to the SARC-F. For the calf circumference cut-off points of \<31 cm and \<33 cm and for the mid-upper arm circumference cut-off points of \<25 cm and \<31 cm were used for the sensitivity and specificity analyses.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 30, 2019
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 1, 2018
Actual (reported)March 2, 2019
Actual (reported)May 30, 2019
Actual (reported)February 6, 2022
Actual (reported)February 16, 2022
Actual (reported)sarcopenia prevalance
number
Day 1
SARC-F score
number
Day 1
mid-upper arm circumference
cm
Day 1
calf circumference
cm
Day 1
Appendicular skeletal muscle mass index
kg/m2
Day 1
SARC-F, CC, MUAC
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Community-dwelling participants aged 65 and over who applied to the geriatrics outpatient clinic for any reason.
Ege University
Izmir, Bornova, 35100, Turkey (Türkiye)
Abd-El-Gawad WM, Abou-Hashem RM, El Maraghy MO, Amin GE. The validity of Geriatric Nutrition Risk Index: simple tool for prediction of nutritional-related complication of hospitalized elderly patients. Comparison with Mini Nutritional Assessment. Clin Nutr. 2014 Dec;33(6):1108-16. doi: 10.1016/j.clnu.2013.12.005. Epub 2013 Dec 28.
Ates Bulut E, Soysal P, Dokuzlar O, Kocyigit SE, Aydin AE, Yavuz I, Isik AT. Validation of population-based cutoffs for low muscle mass and strength in a population of Turkish elderly adults. Aging Clin Exp Res. 2020 Sep;32(9):1749-1755. doi: 10.1007/s40520-019-01448-4. Epub 2020 Jan 2.
yasemin A Atik-Altinok, PhD
Ege University
Devrim Bozkurt, Assoc Prof
Ege University
Sumru Savaş, Assoc Prof
Ege University
Reci Meseri, Assoc Prof
Ege University
190 participants (actual enrollment reported by the registry).
First Submitted
February 6, 2022
First Posted
February 16, 2022
Study Start
July 1, 2018
Actual (reported)Interest of a Tongue Strength Measurement in the Screening for Sarcopenia in Hospitalized Elderly Patients
Contact the study team to confirm eligibility.
Bahat G, Yilmaz O, Kilic C, Oren MM, Karan MA. Performance of SARC-F in Regard to Sarcopenia Definitions, Muscle Mass and Functional Measures. J Nutr Health Aging. 2018;22(8):898-903. doi: 10.1007/s12603-018-1067-8.
Fu X, Tian Z, Thapa S, Sun H, Wen S, Xiong H, Yu S. Comparing SARC-F with SARC-CalF for screening sarcopenia in advanced cancer patients. Clin Nutr. 2020 Nov;39(11):3337-3345. doi: 10.1016/j.clnu.2020.02.020. Epub 2020 Feb 22.
Sergi G, De Rui M, Veronese N, Bolzetta F, Berton L, Carraro S, Bano G, Coin A, Manzato E, Perissinotto E. Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults. Clin Nutr. 2015 Aug;34(4):667-73. doi: 10.1016/j.clnu.2014.07.010. Epub 2014 Jul 24.
da Luz MCL, Pinho CPS, Bezerra GKA, da Conceicao Chaves de Lemos M, da Silva Diniz A, Cabral PC. SARC-F and SARC-CalF in screening for sarcopenia in older adults with Parkinson's disease. Exp Gerontol. 2021 Feb;144:111183. doi: 10.1016/j.exger.2020.111183. Epub 2020 Dec 3.
Hajaoui M, Locquet M, Beaudart C, Reginster JY, Petermans J, Bruyere O. Sarcopenia: Performance of the SARC-F Questionnaire According to the European Consensus Criteria, EWGSOP1 and EWGSOP2. J Am Med Dir Assoc. 2019 Sep;20(9):1182-1183. doi: 10.1016/j.jamda.2019.05.021. No abstract available.
Drey M, Ferrari U, Schraml M, Kemmler W, Schoene D, Franke A, Freiberger E, Kob R, Sieber C. German Version of SARC-F: Translation, Adaption, and Validation. J Am Med Dir Assoc. 2020 Jun;21(6):747-751.e1. doi: 10.1016/j.jamda.2019.12.011. Epub 2020 Jan 21.
Fulden Saraç, Prof Dr
Ege University
Fehmi Akçiçek, Prof Dr
Ege University
Primary Completion
March 2, 2019
Actual (reported)Study Completion
May 30, 2019
Actual (reported)Last Updated
March 7, 2022
Record last verified: 2022-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: